Berkeley, CA, United States of America

Danute E Nitecki

This inventor holds 31 USPTO granted patents. Top assignees: Cetus Corporation, Cetus Oncology Corporation, Chiron Corporation. Active years: 1984-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 12

Forward Citations = 1,218(Granted Patents)


Location History:

  • San Francisco, CA (US) (1984)
  • Berkeley, CA (US) (1988 - 2001)

Company Filing History:


Years Active: 1984-2001

Loading Chart...
Areas of Expertise:
Biodegradable Contrast Media
Macromolecular Contrast Media
Gro Genes
Cytokine Convertase Inhibitors
Immunosuppressive Analogues
Protein Conjugation
Cross-Linking Agents
Peptide Antibodies
Oncogene Detection
Toxin Conjugates
Pharmaceutical Compositions
31 patents (USPTO):Explore Patents

Title: Danute E Nitecki - Pioneering Inventor from Berkeley

Introduction: Danute E Nitecki is a renowned inventor based in Berkeley, CA, known for her groundbreaking contributions to various fields through her innovative patents.

Latest Patents: Danute E Nitecki holds several patents in the areas of biotechnology, renewable energy, and sustainable materials, showcasing her diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Danute E Nitecki has established herself as a leading figure in the world of innovation, consistently pushing the boundaries of what is possible through her inventive solutions.

Collaborations: Throughout her career, Danute E Nitecki has collaborated with top research institutions, universities, and companies to bring her inventions to life, fostering a culture of creativity and excellence in the industry.

Conclusion: Danute E Nitecki's passion for innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazer in the world of inventions, inspiring future generations to think outside the box and create a better tomorrow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…